Asymmetric hydrogenation of prochiral amino ketones to amino alcohols for pharmaceutical use

Accounts of Chemical Research

Volumn 40, Issue 12, 2007, Pages 1367-1376

  Klingler, Franz Dietrich ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOALCOHOL; KETONE; LOBELINE;

CATALYSIS; CHEMISTRY; HYDROGENATION; REVIEW; STEREOISOMERISM;

AMINO ALCOHOLS; CATALYSIS; CHEMISTRY, PHARMACEUTICAL; HYDROGENATION; KETONES; LOBELINE; STEREOISOMERISM;

EID: 38049086642     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar700100e     Document Type: Review

References (79)

1. Newman, P. Optical Resolution Procedures for Chemical Compounds; Optical Resolution Information Center, Manhattan College: Riverdale, NY, 1984; 4 vols.
2. Periasamy, M. Novel methods of resolving racemic diols and amino alcohols. Aldrichim. Acta 2002, 35, 89-101.
3. (a) Bornscheuer, U. T. Trends and challenges in enzyme technology. Adv. Biochem. Eng. Biotechnol. 2005, 100, 181-203.
4. (b) Stürmer, R. (BASF AG) A chemoenzymic synthesis of enantiomerically pure amino alcohols. World Patent WO 2005073215, 2005.
5. Baldwin, J. E.; Dyer, R. L.; Ng, S. C.; Pratt, A. J.; Russell, M. A. Application of E. coli aspartate transaminase to amino acid synthesis. Tetrahedron Lett. 1987, 28, 3745-3746.
6. Hashiguchi, S.; Kawada, A.; Natsugari, H. Baker's yeast reduction of N-protected methyl 4-amino-3-oxobutanoates and 3-oxopentanoates. Synthesis 1992, 4, 403-408.
7. Noyori, R.; Tomino, I.; Yamada, M.; Nishizawa, M. Asymmetric synthesis via axially dissymmetric molecules. 7. Synthetic applications of the enantioselective reduction by binaphthol-modified lithium aluminium hydride reagents. J. Am. Chem. Soc. 1984, 106, 6717-6725.
8. Midland, M. M. Asymmetric reductions with organoborane reagents. Chem. Rev. 1989, 89, 1553-1561.
9. Brown, H. C.; Ramachandran, P. V. Asymmetric reduction with chiral organoboranes based on α-pinene. Acc. Chem. Res. 1992, 25, 16-24.
10. Dhar, R. K. Diisopinocamphenylchloroborane, (DIP-chloride), an excellent chiral reducing reagent for the synthesis of secondary alcohols of high enantiomeric purity. Aldrichim. Acta 1994, 27, 43-51.
11. 3 agonists. Bioorg. Med. Chem. Lett. 2001, 11, 757-760.
12. Corey, E. J.; Bakshi, R. K.; Shibata, S. Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications. J. Am. Chem. Soc. 1987, 109, 5551-5553.
13. Studer, M.; Blaser, H.-U.; Exner, C. Enantioselective hydrogenation using heterogeneous modified catalysts: An update. Adv. Synth. Catal. 2003, 345, 45-65.
14. Akabori, S.; Izumi, Y.; Fujii, Y.; Sakurai, S. An asymmetric catalyst. Nippon Kagaku Zasshi, 1956, 77, 1374-1378;
15. Chem. Abstr. 53, 28795.
16. Pugin, B.; Blaser, H.-U. The immobilization of rhodium-4- (diphenylphosphino)-2-(diphenylphosphino-methyl)pyrrolidine (Rh-PPM) complexes: A systematic study. Adv. Synth. Catal. 2006, 348, 1743-1751.
17. de Vries, J. G., Elsevier, C. J., Eds. Handbook of Homogeneous Hydrogenation; Wiley-VCH: Weinheim, Germany, 2007;Part IV; pp 745-1326.
18. Jacobson, E. N., Pfaltz, A., Yamamoto, H., Eds. Comprehensive Asymmetric Catalysis; Springer: Berlin, 1999; pp 199-318.
19. Blaser, H.-U.; Malan, C.; Pugin, B.; Spindler, F.; Steiner, H.; Studer, M. Selective hydrogenation for fine chemicals: Recent trends and new developments. Adv. Synth. Catal. 2003, 345, 103-151.
20. Hayashi, T.; Katsumura, A.; Konishi, M.; Kumada, M. Asymmetric synthesis of 2-amino-1-arylethanols by catalytic asymmetric hydrogenation. Tetrahedron Lett. 1979, 20, 425-428.
21. Inoguchi, K.; Sakuraba, S.; Achiwa, K. Design concepts for developing highly efficient chiral bisphosphine ligands in rhodium-catalyzed asymmetric hydrogenations. Synlett 1992, 169-178.
22. Achiwa, K. Asymmetric hydrogenation with new chiral functionalized bisphosphine-rhodium complexes. J. Am. Chem. Soc. 1976, 98, 8265-8266.
23. Patil, P. N.; Miller, D. D.; Trendelenburg, U. Molecular geometry and adrenergic drug activity. Pharmacol. Rev. 1974, 26, 323-392.
24. Cushny, A. R. The action of optical isomers. III. Adrenalin. J. Physiol. 1908, 37, 130-138.
25. von Euler, U. S. Identification of the sympathomimetic ergone in adrenergic nerves of cattle (Sympathin N) with laevo-noradrenaline. Acta Physiol. Scand. 1948, 16, 63-74.
26. Knorr, H.; Reichl, R.; Traunecker, W.; Knappen, F.; Brandt, K. Asymmetrische Synthese des (R)(-)- und (S)(+)-Etilefrins durch enantioselektive Hydrierung und die Wirkungen der Enantiomere im Tierexperiment. Arzneim.-Forsch./Drug Res. 1984, 34, 1709-1713.
27. (a) von Bruchhausen, F., Dannhardt, G., Ebel, S., Frahm, A. W., Hackenthal, E., Holzgrabe, U., Eds. Hagers Handbuch der pharmazeutischen Praxis, 5th ed.; Springer: Berlin 1994; Vol. 9; pp 168-171.
28. (b) The Merck Index, 12th ed.; Merck & Co. Inc.: Whitehouse Station, NJ, 1996; p 1255.
29. (c) Negwer, M. Organic-chemical drugs and their synonyms; Akademie Verlag: Berlin, Germany, 1994; Vol. 1, p 340.
30. (a) Legerlotz, H. Optically active monohydroxyphenylalkylamines, German Patent DE 543529 1929.
31. (b) Legerlotz, H. (assigned to Boehringer Ingelheim). Monohydric amino alcohols and their derivatives, German Patent DE 566578, 1932.
32. (c) Legerlotz, H. Optically active amino alcohols, German Patent DE 585164, 1933.
33. (a) Bretschneider, H. Phenylalkanolamines VII. Acetyl derivatives of optically active (methylamino- methyl)-(3-hydroxyphenyl)carbinol (Adrianol, m-Synephrine) and the synthesis of (+)-dimethyl-aminoethyl-3-oxyphenylcarbinol. Monatsh. Chem. 1949, 80, 517-529.
34. (b) Bretschneider, H. Phenylalkanolamines. VIII. Walden inversion of optically active (methylamino-methyl)-(3-hydroxyphenyl)carbinol according to H. Legerlotz. Monatsh. Chem. 1949, 80, 530-549.
35. Sergievskaya, S. I.; Ravdel, G. A. Synthesis of m-amino(hydroxyl) phenyl-β-(methylamino)ethanols and the catalytic reduction of m-nitroacetophenone. Zh. Obshch. Khim. 1952, 22, 496-501.
36. Bergmann, E. D.; Sulzbacher, M. A new synthesis of 1-(m- and p-hydroxyphenyl)-2-methylaminoethanol (m- and p-Sympathol). J. Org. Chem. 1951, 16, 84-89.
37. (a) Hukki, J.; Honkanen, E. Synthesis of phenolic alkamine ethers of adrenaline and some related compounds. Acta Chim. Scand. 1959, 13, 329-333.
38. (b) Russell, P. B.; Childress, S. J. New route to phenylephrine. J. Pharm. Sci. 1961, 50, 713.
39. (c) Britten, A. Z. A new route to D,L-phenylephrine. Chem. Ind. 1968, 24, 771-772.
40. (d) Pandey, R. K.; Upadhyay, P. K.; Kumar, P. Enantioselective synthesis of (R)-phenylephrine hydrochloride. Tetrahedron Lett. 2003, 44, 6245-6246.
41. Takeda, H.; Tachinami, T.; Aburatani, M.; Takahashi, H.; Morimoto, T.; Achiwa, K. Practical asymmetric synthesis of (R)(-)-phenylephrine hydrochloride catalyzed by (2R,4R)-MCCPM-rhodium complex. Tetrahedron Lett. 1989, 30, 367-370.
42. Miyashita, A.; Yasuda, A.; Takaya, H.; Toriumi, K.; Ito, T.; Souchi, T.; Noyori, R. Synthesis of 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (BINAP), an atropisomeric chiral bis(triaryl)phosphine, and its use in the rhodium(I)-catalyzed asymmetric hydrogenation of α-(acylamino)acrylic acids. J. Am. Chem. Soc. 1980, 102, 7932-7934.
43. Roucoux, A.; Agbossou, F.; Mortreux, A.; Petit, F. New alkylarylamidophosphinephosphinites as chiral diphosphines for asymmetric hydrogenation of activated keto compounds. Tetrahedron: Asymmetry 1993, 4, 2279-2282.
44. Gridnev, I. D.; Imamoto, T. On the mechanism of stereoselection in Rh-catalyzed asymmetric hydrogenation: A general approach for predicting the sense of enantioselectivity. Acc. Chem. Res. 2004, 37, 633-644.
45. Klingler, F. D.; Wolter, L.; Dietrich, W. (Boehringer Ingelheim). Method for producing L-phenylephrine hydrochloride, European Patent EP 1147075 1999; U.S. Patent 6,187,956, 2001.
46. Abraham, D. J., Ed. Burger's Medicinal Chemistry and Drug Discovery, Wiley-Interscience: Hoboken, NJ, 2003; Vol. 6, Chapter 1.
47. (a) Szulczewski, D. H.; Hong, W.-H. In Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press: New York, 1978; Vol. 7; pp 193-229.
48. (b) Loewe, H. Zum fünfzigjährigen Jubiläum der ersten Hormon-Synthese: Suprarenin und seine Derivate. Arzneim.-Forsch. 1954, 4, 583-598.
49. Klingler, F. D.; Wolter, L. (Boehringer Ingelheim). Process for the production of adrenaline, European Patent EP 1210318, 2000; U.S. Patent 6,218,575, 2001.
50. Achiwa, K. Chiral phosphinopyrrolidine compounds and their use for asymmetric synthesis of optically active compounds., Japanese Patent JP86-147167, 1986.
51. Mortreux, A.; Karim, A. Rhodium-catalyzed enantioselective hydrogenation of functionalized ketones. In Handbook of Homogeneous Hydrogenation; de Vries, J. G., Elsevier, C. J., Eds.; Wiley-VCH: Weinheim, Germany 2007;Part IV, pp 1178-1179.
52. Yoshikawa, K.; Yamamoto, N.; Murata, M.; Awano, K.; Morimoto, T.; Achiwa, K. A new type of atropisomeric biphenylbisphosphine ligand, (R)-MOC-BIMOP and its use in efficient asymmetric hydrogenation of α-amino ketone and itaconic acid. Tetrahedron: Asymmetry 1992, 3, 13-16.
53. Mashima, K.; Kusano, K.; Sato, N.; Matsumura, Y.; Nozaki, K.; Kumobayashi, H.; Sayo, N.; Hori, Y.; Ishizaki, T.; Akutagawa, S.; Takaya, H. Cationic BINAP-Ru(II) halide complexes: Highly efficient catalysts for stereoselective asymmetric hydrogenation of α- and β-functionalized ketones. J. Org. Chem. 1994, 59, 3064-3076.
54. Devocelle, M.; Agbossou, F.; Mortreux, A. Asymmetric hydrogenation of α,β-and α-amino ketones catalyzed by cationic rhodium(I){AMPP} complexes. Synlett 1997, 1306-1308.
55. 2-(diphosphine)(1,2-diamine) complexes. J. Am. Chem. Soc. 2000, 122, 6510-6511.
56. Klingler, F. D.; Dietrich, W.; Lenhart, A. (Boehringer Ingelheim). Unpublished results.
57. Kreye, P.; Lenhart, A.; Klingler, F. D. (Boehringer Ingelheim). Procedure for preparation of (R)-salbutamol by asymmetric hydrogenation of salbutamone using rhodium and chiral divalent phosphine catalyst, German Patent DE 10249576, 2004.
58. Blaser, H.-U.; Gamboni, R.; Pugin, B.; Rihs, G.; Sedelmeier, G.; Schaub, B.; Schmidt, E.; Schmitz, B.; Spindler, F.; Wetter, H. J. Route Evaluation for the Production of (R)-Levoprotiline. In Process Chemistry in the Pharmaceutical Industry, Gadamasetti, K. G., Ed.; Marcel Dekker Inc.: New York, 1999; pp 189-199.
59. Takeda, H.; Tachinami, T.; Aburatani, M.; Takahashi, H.; Morimoto, T.; Achiwa, K. Asymmetric reactions catalyzed by chiral metal complexes. XXVII. Efficient asymmetric hydrogenation of α-aminoacetophenone derivatives leading to practical synthesis of (S)-(-)-levamisole. Tetrahedron Lett. 1989, 30, 363-366.
60. Müller-Bötticher, H. (Boehringer Ingelheim). Unpublished results.
61. Brieden, W. (Lonza AG) Preparation of optically active 3-hydroxyquinuclidine, European Patent EP 785198A1, 1997.
62. Takahashi, H.; Sakuraba, S.; Takeda, H.; Achiwa, K. Asymmetric reactions catalyzed by chiral metal complexes. 41. Highly efficient asymmetric hydrogenation of amino ketone derivatives leading to practical syntheses of (S)-propranolol and related compounds. J. Am. Chem. Soc. 1990, 112, 5876-5878.
63. Sakuraba, S.; Achiwa, K. Asymmetric reactions catalyzed by chiral metal complexes. XLVIII. Practical asymmetric synthesis of (R)-fluoxetine hydrochloride catalyzed by (2S,4S)-4-dicyclohexylphosphino-2- diphenylphosphinomethyl-1-(N-methylcarbamoyl)pyrrolidine-rhodium complex. Synlett 1991, 689-690.
64. Kreye P. (Boehringer Ingelheim) Unpublished results.
65. Lonza AG, Switzerland (inventors not disclosed). Process for the asymmetric hydrogenation of β-amino ketones using transition metal complexes of chiral bidentate phosphines as catalysts, European Patent EP 1510517, 2003.
66. Liu, D.; Gao, W.; Wang, C.; Zhang, X. Practical synthesis of enantiopure γ-amino alcohols by rhodium-catalyzed asymmetric hydrogenation of β-secondary-amino ketones. Angew. Chem., Int. Ed. 2005, 44, 1687-1689.
67. (a) Millspaugh, C. F. American Medicinal Plants, Dover Publications: New York, 1974; pp 385-388.
68. (b) King, M. J.; Hosmer, H. R.; Dresbach, M. Physiological reactions induced by alpha-lobelin. I. Intravenous injections during anesthesia and certain other forms of depression. J. Pharmacol. Exp. Ther. 1928, 32, 241-272.
69. Reynolds, M. Treatment and system for nicotine withdrawal, U.S. Patent 6,409,991, 2002.
70. Crooks, P. A.; Dwoskin, L. P. (University of KY Research Foundation) Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders, U.S. Patent 5,830,904, 1998.
71. Crooks, P. A.; Dwoskin, L. P. (University of KY Research Foundation) Use of lobeline compounds in the treatment of central nervous system diseases and pathologies, U.S. Patent 6,087,376, 2000.
72. Ebnoether, A. Alkaloids. IX. Mutarotation of lobeline cis-trans isomers in the lobeline alkaloid series. Helv. Chim. Acta 1958, 41, 386-396.
73. Wieland, H.; Dragendorff, O. Die Konstitution der Lobelia-Alkaloide. Justus Liebigs Ann. Chem. 1929, 473, 83-101.
74. (a) Wieland, H. (assigned to C.H. Boehringer Sohn). Process for preparing Lobelia alkaloids, their derivatives and allied compounds, U.S. Patent 1,946,345, 1934.
75. (b) Schöpf, C.; Lehmann, G. Die Synthese des Tropinons, Pseudopelletierins, Lobelanins und verwandter Alkaloide unter physiologischen Bedingungen. Justus Liebigs Ann. Chem 1935, 518, 1-37.
76. Felpin, F. X.; Lebreton, J. History, chemistry and biology of alkaloids from Lobelia inflate. Tetrahedron 2004, 60, 10127-10153.
77. Scheuing, G.; Marion, L. In The Alkaloids; Manske, R. H. F., Holmes, H. L., Eds.; Academic Press: New York, 1950; pp 196-197.
78. Sobotta, R.; Klingler, F. D. (Boehringer Ingelheim). Process for manufacturing of chiral lobelin, U.S. Patent 2006014791 2006.
79. Achiwa, K. Chiral phosphinopyrrolidine compounds and their use for asymmetric synthesis of optically active compounds, European Patent EP 0251164, 1987.